Filters

Latanoprostene bunod manufacturers

Filters

None products found

latanoprostene bunod

Eye drops 0.24 mg/ml - 2.5 ml, 5 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Vietnam
Manufacturer #376
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 14 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.